Real-world impact of adjuvant chemotherapy on patients with pT4N0 colon cancer

To R (2024): Personalised adjuvant chemotherapy in stage II colon cancer: a health economic analysisПодробнее

Highlights on adjuvant chemotherapy of stage II colon cancer: The DYNAMIC TrialПодробнее

DYNAMIC: ctDNA guiding adjuvant chemotherapy in stage II colon cancerПодробнее

Assessing the role of adjuvant chemotherapy in stage III dMMR colon cancerПодробнее

S2 Episode 5: Adjuvant Chemo in Colorectal Cancer: What's Working Now?Подробнее

Adjuvant chemotherapy for patients with rectal cancerПодробнее

Real-world monitoring of ctDNA reliably predicts cancer recurrence in resected stages I-III CRCПодробнее

Risk model to predict delivery of adjuvant chemotherapyПодробнее

COBRA: ctDNA to help decide which patients with colon cancer will benefit from adjuvant chemotherapyПодробнее

At what stage of bowel cancer is adjuvant chemotherapy used? - Online interviewПодробнее

It Took A YEAR To Figure Out I Had STAGE 4 Colorectal Cancer!Подробнее

IDEA Collaboration; Impact on Adjuvant TherapyПодробнее

Life of Young Colon Cancer SurvivorПодробнее

Impact of timing of perioperative chemotherapy on OS in patients with CRC liver metastasesПодробнее

Adjuvant Chemotherapy in Older Patients with Stage III Colon CancerПодробнее

NRG-GI005: ctDNA predicts adjuvant chemo in stage II colon cancerПодробнее

Dion Morton, Philip Quirke – Neoadjuvant chemotherapy for advanced colon cancerПодробнее

Dr. Venook Discusses Adjuvant Chemotherapy Duration in CRCПодробнее

Neoadjuvant and adjuvant chemotherapy with TME in T3 rectal cancerПодробнее